Lifestyle intervention remains a core component of obesity management, alongside the emergence of more potent pharmacotherapy ...
Novo Nordisk NVO announced that the Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The ADA 2024 Standards of Care includes updates on ...
EMA has recommended Ablymico and Liraglutide STADA and an oral formulation of Wegovy, potentially expanding GLP-1 treatment ...
In 2003, the U.S. Preventive Services Task Force recommended that clinicians screen all adults for obesity (body-mass index, >30) and offer intensive behavioral counseling to obese adults (Journal ...
The medication can reduce risk of cardiovascular disease and improve quality of life for those living with CVD. Nutrition and ...
The system for diagnosing and managing obesity can no longer be about just body mass index (BMI), which is excluding many people who would benefit from obesity treatment. A new framework for the ...
The authors advocate for a consideration of 2 distinct phases of obesity management (ie, active weight loss and maintenance of weight loss) to allow substantially more people access to antiobesity ...
Credit: Getty Images The AACE consensus statement emphasizes improvement of overall health in addition to weight reduction among adults with obesity and adiposity-based chronic disease. Test your ...
A meta-analysis of 32 studies and 43,618 adults presented at the European Congress on Obesity in Istanbul, Turkey (May 12–15) ...